300676.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:04):

Stats
Today's Volume	2.36M
Average Volume	3.40M
Market Cap	15.61B
EPS	CNY0.0445 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	173.09
ATR14	CNY0.0460 (0.12%)

Volume Correlation

Long: -0.04 (neutral)

Short: -0.53 (weak negative)

Signal:(36.427) Neutral

BGI Genomics Co., Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BGI Genomics Co., Ltd. Correlation - Currency/Commodity

0.05
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.57
( weak )

-0.45
( neutral )

-0.69
( moderate negative )

BGI Genomics Co., Ltd. Financials

Annual	2023
Revenue:	CNY4.35B
Gross Profit:	CNY4.35B (100.00 %)
EPS:	CNY0.220

Q4	2023
Revenue:	CNY1.21B
Gross Profit:	CNY1.21B (100.00 %)
EPS:	CNY0.0508

Q3	2023
Revenue:	CNY1.07B
Gross Profit:	CNY566.55M (52.82 %)
EPS:	CNY0.0454

Q2	2023
Revenue:	CNY1.12B
Gross Profit:	CNY521.41M (46.67 %)
EPS:	CNY0.0254

Financial Reports:

No articles found.

BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.